TAKEDA PHARMACEUTICAL COMPANY LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,089 JPY | -0.02% |
|
+0.49% | +0.86% |
| 04-26 | EU Panel Backs Approval of Takeda’s Colorectal Cancer Drug | MT |
| 04-26 | Hutchmed notes CHMP's positive opinion for fruiquintinib approval | AN |
Chart calendar Takeda Pharmaceutical Company Limited
f35f30408170a01d72b44b5941b.uqwPrk2EZMf26NnOO94ozwEkulp92OtFSo2n1Qy5d-E.6Zg75hLKKo6jor2laphxqmt04AlJ6cYaPfvw5lPPB9jPwHbDOvUphY_Y7Q~39a2e7d503aec7ab94f0ec64ac16a8cf
Upcoming events on Takeda Pharmaceutical Company Limited
Past events on Takeda Pharmaceutical Company Limited
| 27/03/2024 | Final dividend |
| 06/03/2024 14:50 | TD Cowen Health Care Conference |
| 01/02/2024 10:59 | Q3 2023 Earnings Release |
| 01/02/2024 10:30 | Q3 2023 Earnings Call |
| 09/01/2024 01:15 | JPMorgan Healthcare Conference |
| 08/12/2023 | American Society of Hematology Meeting |
| 05/12/2023 23:00 | Analyst Meeting - Plasma-Derived Therapies (PDT) |
| 14/11/2023 17:00 | American College of Rheumatology Conference - Abstract Number - L12 |
| 14/11/2023 09:00 | Jefferies London Healthcare Conference |
| 26/10/2023 11:00 | Q2 2023 Earnings Call |
| 26/10/2023 07:00 | Q2 2023 Earnings Release |
| 27/09/2023 | Ex-dividend day for dividende intermédiaire |
| 11/09/2023 20:35 | Morgan Stanley Healthcare Conference |
| 27/07/2023 11:00 | Q1 2023 Earnings Call |
| 27/07/2023 07:00 | Q1 2023 Earnings Release |
| 27/06/2023 | Annual General Meeting |
| 07/06/2023 | European Hematology Association Hybrid Congress |
| 01/06/2023 | American Society of Clinical Oncology Conference |
| 11/05/2023 11:00 | Q4 2022 Earnings Call |
| 11/05/2023 10:57 | Q4 2022 Earnings Release |
Past dividends on Takeda Pharmaceutical Company Limited
| 27/03/2024 | Final Payment 94 JPY |
| 27/09/2023 | Interim Payment 94 JPY |
| 29/03/2023 | Final Payment 90 JPY |
| 28/09/2022 | Interim Payment 90 JPY |
| 29/03/2022 | Final Payment 90 JPY |
| 28/09/2021 | Interim Payment 90 JPY |
| 29/03/2021 | Final Payment 90 JPY |
| 28/09/2020 | Interim Payment 90 JPY |
| 29/03/2020 | Final Payment 90 JPY |
| 26/09/2019 | Interim Payment 90 JPY |
Annual results
| Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 2 097 200 2 154 309 -2.65% | 3 291 200 3 317 708 -0.8% | 3 197 812 3 220 743 -0.71% | 3 569 006 3 490 146 2.26% | 4 027 478 3 985 941 1.04% | 4 099 317 |
|
EBITDA Million JPY | Released Forecast Spread | 477 415 601 020 -20.57% | 684 057 779 587 -12.25% | 1 068 940 1 159 038 -7.77% | 1 043 995 1 144 518 -8.78% | 1 154 905 1 252 287 -7.78% | 1 046 202 |
|
EBIT Million JPY | Released Forecast Spread | 205 000 184 951 10.84% | 100 400 37 690 166.38% | 509 269 546 585 -6.83% | 460 844 510 133 -9.66% | 490 505 538 048 -8.84% | 267 999 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 94 896 115 956 -18.16% | -60 754 -181 179 66.47% | 366 235 435 452 -15.9% | 302 571 382 708 -20.94% | 375 090 427 128 -12.18% | 132 641 |
|
Net income Million JPY | Released Forecast Spread | 109 100 118 902 -8.24% | 44 200 -142 632 130.99% | 376 005 293 971 27.91% | 230 059 238 921 -3.71% | 317 017 314 672 0.75% | 134 022 |
|
EPS JPY | Released Forecast Spread | 113 105 7.92% | 28,0 -87,6 131.97% | 241 166 44.73% | 147 153 -3.85% | 204 203 0.77% | 88,1 |
| Announcement Date | 14/05/19 | 13/05/20 | 11/05/21 | 11/05/22 | 11/05/23 | - |
Quarterly results
| Fiscal Period | Marzo | 2020 S1 | 2020 S2 | 2021 S1 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 S1 | 2025 Q3 | 2025 Q4 | 2026 S1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 1 660 200 1 681 000 -1.24% | 1 631 000 1 622 217 0.54% | 1 590 785 1 614 700 -1.48% | 1 794 400 1 799 800 -0.3% | 901 294 848 397 6.23% | 873 289 848 137 2.97% | 972 465 953 850 1.95% | 1 002 340 950 078 5.5% | 1 974 800 2 008 000 -1.65% | 1 096 551 996 345 10.06% | 956 200 954 896 0.14% | 1 058 618 995 797 6.31% | 1 043 089 990 336 5.33% | 2 101 707 2 062 000 1.93% | 1 111 200 1 000 980 11.01% | 899 902 | 1 038 000 | 1 044 000 | 2 034 000 | 1 106 000 | 959 000 | 2 060 000 |
|
EBITDA Million JPY | Released Forecast Spread | 249 972 | 340 072 | 133 355 | 291 975 347 150 -15.89% | 207 900 | |||||||||||||||||
|
EBIT Million JPY | Released Forecast Spread | 50 300 -43 100 216.71% | 50 100 -18 766 366.97% | 215 588 267 800 -19.5% | 346 000 357 150 -3.12% | 116 484 121 850 -4.4% | -1 619 61 374 -102.64% | 150 515 166 025 -9.34% | 104 485 118 969 -12.17% | 255 000 302 000 -15.56% | 146 990 180 100 -18.38% | 88 600 118 453 -25.2% | 168 571 130 200 29.47% | -49 341 93 028 -153.04% | 119 230 257 950 -53.78% | 104 900 59 467 76.4% | 50 750 | 94 000 | 185 500 | 210 500 | |||
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | -27 557 -109 100 74.74% | -33 197 -89 335 62.84% | 125 561 209 500 -40.07% | 284 425 269 500 5.54% | 72 193 135 721 -46.81% | -54 047 33 814 -259.84% | 155 473 143 488 8.35% | 64 549 49 844 29.5% | 220 022 278 000 -20.86% | 107 153 169 587 -36.82% | 47 900 59 386 -19.34% | 135 033 111 968 20.6% | -95 980 103 284 -192.93% | 39 053 211 450 -81.53% | 61 300 76 613 -19.99% | 18 376 | 42 500 | 92 500 | 127 500 | |||
|
Net income Million JPY | Released Forecast Spread | 33 200 -114 000 129.12% | 11 000 -188 647 105.83% | 86 548 134 840 -35.81% | 183 600 186 500 -1.55% | 57 769 61 132 -5.5% | -11 358 15 964 -171.15% | 105 014 105 471 -0.43% | 61 786 39 044 58.25% | 166 800 197 400 -15.5% | 119 127 129 087 -7.72% | 31 100 28 220 10.21% | 89 395 88 267 1.28% | -48 030 93 784 -151.21% | 41 365 192 000 -78.46% | 105 700 86 163 22.68% | -18 644 | 32 500 | 70 500 | 97 500 | |||
|
EPS JPY | Released Forecast Spread | 21,0 -73,1 128.73% | 55,5 72,7 -23.73% | 117 119 -1.6% | 37,0 38,9 -4.85% | -6,95 5,97 -216.51% | 67,9 63,9 6.26% | 40,1 38,2 4.75% | 108 128 -15.43% | 76,7 97,7 -21.49% | 20,0 10,7 87.15% | 57,5 39,0 47.55% | -31,0 38,6 -180.36% | 26,5 | 67,4 21,7 211.01% | 0,77 | 20,7 | 44,9 | 62,1 | ||||
| Announcement Date | 31/10/19 | 13/05/20 | 29/10/20 | 28/10/21 | 03/02/22 | 11/05/22 | 28/07/22 | 27/10/22 | 27/10/22 | 02/02/23 | 11/05/23 | 27/07/23 | 26/10/23 | 26/10/23 | 01/02/24 | - | - | - | - | - | - | - |
More events
Past sector events for Takeda Pharmaceutical Company Limited
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4502 Stock
- Calendar Takeda Pharmaceutical Company Limited
